Recommended
Articles to display in the recommended sidebar
Trump threatens 200 percent tariffs on pharmaceuticals
At a cabinet meeting on Tuesday, US President Donald Trump announced plans to impose sharply increased import tariffs: 50 percent...
AbbVie acquires Capstan Therapeutics for up to $2,1 billion
The deal gives AbbVie access to a method for...
GLP-1 drugs drive pharmaceutical boom to 2030
Evaluate has compiled a report showing that...
FDA introduces fast track for drugs of national importance
Yesterday, the US Food and Drug Administration (FDA) announced that...
Monetization of future royalties increasingly popular
Monetization of royalties has become an increasingly popular...
Biotech funding plummets in the wake of Trump's policies
During the month of May, biotechnology sector funding fell by 57...
700 million euros allocated to Nordic life science
The Nordic investment company Impilo has closed its Fund...
BioNTech and Bristol Myers Squibb sign monster deal
BioNTech and Bristol Myers Squibb have signed a...
From the LSD of the 60s to the JRT of the future
A new molecule, JRT, could be a breakthrough...
The pharmaceutical industry's call to the EU: Act!
A large number of global pharmaceutical giants are threatening to move...
New generation of cancer drugs challenges Keytruda
PD-1 inhibitors have revolutionized cancer treatment over the past decade, with...
Notes
Mentice consolidates operations to Denver
Bio-Works secures million-dollar order from global pharmaceutical company
OncoZenge receives investment proceeds from Yangtian Bio-Pharmaceutical
Xspray Pharma confirms bioequivalence for XS003
Evaxion converts debt of EUR 3,5 million
NEWSLETTER
NEWS
AI-designed proteins are created in seconds
The price of Leqembi needs to be lowered in Japan
Merck gears up in lung diseases with giant acquisition
Upcoming events!
Investing in Life Science
Discover unparalleled opportunities, set in the vibrant heart of Stockholm. This premier event unites forward-thinking investors and business leaders to...
Life Science Summit
The Nordic region's leading forum for early-stage and growth-phase life science companies. The Summit bridges innovation and capital by providing...
You deserve the best!
Unlock our premium content: Become a subscriber!
Create Account
Chronicles
The market is taking Trump's tariff threat in stride
The EU's new life science strategy – a step in the right direction or just fluff?
